Literature DB >> 17607902

The discriminant-function test: a marker of Th1/Th2 cell cytokine secretion and breast tumour oestrogen synthesis.

M J Reed1.   

Abstract

Thirty years ago, the discriminant-function test (the ratio of urinary androgen : glucocorticoids) was developed as a marker for women who subsequently developed breast cancer. At that time, it was not clear why this test had a predictive value, but recent research has suggested that androgens and glucocorticoids may have a crucial role in regulating cytokine production by Th1/Th2 cells. Decreased production of the adrenal androgen dehydroepiandrosterone and its sulphate is associated with the production of Th2-type cytokines, some of which have been shown to stimulate markedly the activities of the enzymes that are involved in oestrogen synthesis in breast-cancer cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 17607902     DOI: 10.1016/s1357-4310(95)92435-3

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  4 in total

1.  Adverse life events and breast cancer. Association may be due to imbalance in ratio of adrenal androgens to glucocorticoid.

Authors:  M J Reed; M W Ghilchik
Journal:  BMJ       Date:  1996-03-30

2.  The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-beta1) levels in normal healthy blood donors.

Authors:  D G Young; G Skibinski; J I Mason; K James
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

3.  Urinary androgens and breast cancer risk: results from a long-term prospective study based in Guernsey.

Authors:  D Y Wang; D S Allen; B L De Stavola; I S Fentiman; J Brussen; R D Bulbrook; B S Thomas; J L Hayward; M J Reed
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

4.  Bacterial Lipopolysaccharides Induce Steroid Sulfatase Expression and Cell Migration through IL-6 Pathway in Human Prostate Cancer Cells.

Authors:  Hee-Jung Im; Na-Hee Park; Yeo-Jung Kwon; Sangyun Shin; Donghak Kim; Young-Jin Chun
Journal:  Biomol Ther (Seoul)       Date:  2012-11       Impact factor: 4.634

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.